Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bee venom enhances guanylate cyclase activity.

D L Vesely

    Science (New York, N.Y.)
    |July 17, 1981
    PubMed
    Summary

    Bee venom and its enzyme phospholipase A2 significantly boost guanylate cyclase activity in various rat organs. This finding highlights potential therapeutic applications for bee venom components.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

    European journal of clinical investigation·2010
    Same author

    Cardiac hormones activate ERK 1/2 kinases in human fibroblasts.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
    Same author

    Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.

    European journal of clinical investigation·2008
    Same author

    Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.

    Oncogene·2006
    Same author

    Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.

    European journal of clinical investigation·2006
    Same author

    Circadian distribution of hematology variables in subjects with multiple sclerosis.

    La Clinica terapeutica·2006

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Toxicology

    Background:

    • Guanylate cyclase is a crucial enzyme in cellular signaling pathways.
    • Bee venom contains various bioactive compounds, including phospholipase A2.
    • Previous research has explored the biological activities of bee venom components.

    Purpose of the Study:

    • To investigate the effect of bee venom and purified phospholipase A2 on guanylate cyclase activity.
    • To determine the dose-response relationship of bee venom and phospholipase A2 on guanylate cyclase.

    Main Methods:

    • Enzyme activity assays were performed on rat liver, lung, heart, kidney, ileum, and cerebellum.
    • Bee venom and purified phospholipase A2 were used as treatments.
    • Dose-response curves were established to determine effective concentrations.

    Main Results:

    • Bee venom and phospholipase A2 enhanced guanylate cyclase activity two- to threefold across all tested rat organs.
    • Maximal enhancement was observed at low concentrations: 1 microgram/milliliter for bee venom and 1 microunit/milliliter for phospholipase A2.

    Conclusions:

    • Bee venom and phospholipase A2 are potent activators of guanylate cyclase in multiple rat tissues.
    • The findings suggest a potential mechanism for the pharmacological effects of bee venom.

    Related Experiment Videos